NO974921D0 - Kombinasjon av en 5-HT-opptaksinhibitor med en selektiv 5-HT1A antagonist - Google Patents

Kombinasjon av en 5-HT-opptaksinhibitor med en selektiv 5-HT1A antagonist

Info

Publication number
NO974921D0
NO974921D0 NO974921A NO974921A NO974921D0 NO 974921 D0 NO974921 D0 NO 974921D0 NO 974921 A NO974921 A NO 974921A NO 974921 A NO974921 A NO 974921A NO 974921 D0 NO974921 D0 NO 974921D0
Authority
NO
Norway
Prior art keywords
selective
combination
uptake inhibitor
ht1a antagonist
ht1a
Prior art date
Application number
NO974921A
Other languages
English (en)
Other versions
NO317057B1 (no
NO974921L (no
Inventor
John Evenden
Seth-Olov Thorberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO974921D0 publication Critical patent/NO974921D0/no
Publication of NO974921L publication Critical patent/NO974921L/no
Publication of NO317057B1 publication Critical patent/NO317057B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19974921A 1995-04-27 1997-10-24 Kombinasjon av en 5-HT-opptaksinhibitor med en selektiv 5-HT<N>1A</N> antagonist, formulering og kit inneholdende en slik kombinasjon, fremgangsmate for dens fremstilling, og anvendelse derav. NO317057B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501567A SE9501567D0 (sv) 1995-04-27 1995-04-27 A new combination
PCT/SE1996/000526 WO1996033710A1 (en) 1995-04-27 1996-04-23 A combination of a 5-ht uptake inhibitor with a selective 5-ht1a antagonist

Publications (3)

Publication Number Publication Date
NO974921D0 true NO974921D0 (no) 1997-10-24
NO974921L NO974921L (no) 1997-12-18
NO317057B1 NO317057B1 (no) 2004-08-02

Family

ID=20398119

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974921A NO317057B1 (no) 1995-04-27 1997-10-24 Kombinasjon av en 5-HT-opptaksinhibitor med en selektiv 5-HT<N>1A</N> antagonist, formulering og kit inneholdende en slik kombinasjon, fremgangsmate for dens fremstilling, og anvendelse derav.

Country Status (30)

Country Link
US (5) US5962514A (no)
EP (1) EP0822813B1 (no)
JP (1) JPH11504037A (no)
KR (1) KR100419810B1 (no)
CN (1) CN1102386C (no)
AR (1) AR002990A1 (no)
AT (1) ATE216579T1 (no)
BR (1) BR9608252A (no)
CA (1) CA2218181A1 (no)
CZ (1) CZ335697A3 (no)
DE (1) DE69620878T2 (no)
DK (1) DK0822813T3 (no)
EE (1) EE03553B1 (no)
ES (1) ES2175089T3 (no)
HK (1) HK1002853A1 (no)
HU (1) HUP9801946A3 (no)
IL (1) IL117988A0 (no)
IS (1) IS1821B (no)
NO (1) NO317057B1 (no)
NZ (1) NZ306602A (no)
PL (1) PL183997B1 (no)
PT (1) PT822813E (no)
RU (1) RU2183955C2 (no)
SE (1) SE9501567D0 (no)
SK (1) SK282060B6 (no)
TR (1) TR199701254T1 (no)
TW (1) TW458777B (no)
WO (1) WO1996033710A1 (no)
YU (1) YU25696A (no)
ZA (1) ZA962982B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination
SE9703374D0 (sv) * 1997-09-18 1997-09-18 Astra Ab A new combination
WO1999061014A2 (en) * 1998-05-28 1999-12-02 Sepracor Inc. Compositions and methods employing r(-) fluoxetine and other active ingredients
SE9803156D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
SE9803157D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
SE9803158D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
SE9803155D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
US6331233B1 (en) 2000-02-02 2001-12-18 Honeywell International Inc. Tantalum sputtering target with fine grains and uniform texture and method of manufacture
AU9543601A (en) 2000-10-13 2002-04-22 Neurosearch As Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
US20030166554A1 (en) * 2001-01-16 2003-09-04 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US20030185754A1 (en) * 2001-01-16 2003-10-02 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
PL367480A1 (en) * 2001-05-01 2005-02-21 H.Lundbeck A/S The use of enantiomeric pure escitalopram
US7034059B2 (en) 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
US6855735B2 (en) 2002-03-20 2005-02-15 Temple University Of The Commonwealth System Of Higher Education Ketamine treatment of restless legs syndrome
AU2003256430A1 (en) * 2002-08-15 2004-03-03 Wyeth AGONISM OF THE 5HT2a RECEPTOR FOR TREATMENT OF THERMOREGULATORY DYSFUNCTION
US20050032873A1 (en) * 2003-07-30 2005-02-10 Wyeth 3-Amino chroman and 2-amino tetralin derivatives
US7695601B2 (en) * 2006-05-09 2010-04-13 The United States Of America As Represented By The Secretary Of The Army Electrochemical test apparatus and method for its use
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US20160154928A1 (en) * 2013-07-12 2016-06-02 Immuneering Corporation Systems, methods, and environment for automated review of genomic data to identify downregulated and/or upregulated gene expression indicative of a disease or condition
JP7153653B2 (ja) 2017-02-14 2022-10-14 リサーチ トライアングル インスティテュート プロリン系神経ペプチドｆｆ受容体モジュレーター

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698342A (en) * 1985-07-16 1987-10-06 Serotonin Industries Of Charleston Method and compositions for controlling pain, depression and sedation
US5616610A (en) * 1989-12-22 1997-04-01 Astra Aktiebolag (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
CA2218181A1 (en) 1996-10-31
IS1821B (is) 2002-08-27
DE69620878D1 (de) 2002-05-29
IS4585A (is) 1997-10-09
US5962514A (en) 1999-10-05
KR19990008068A (ko) 1999-01-25
ZA962982B (en) 1996-10-28
US6172105B1 (en) 2001-01-09
CN1102386C (zh) 2003-03-05
CZ335697A3 (cs) 1998-06-17
NO317057B1 (no) 2004-08-02
BR9608252A (pt) 1999-05-04
ATE216579T1 (de) 2002-05-15
ES2175089T3 (es) 2002-11-16
SK282060B6 (sk) 2001-10-08
EE9700245A (et) 1998-04-15
RU2183955C2 (ru) 2002-06-27
TR199701254T1 (xx) 1998-02-21
IL117988A0 (en) 1996-08-04
AR002990A1 (es) 1998-05-27
EP0822813B1 (en) 2002-04-24
DK0822813T3 (da) 2002-07-29
DE69620878T2 (de) 2002-11-14
SK142997A3 (en) 1998-12-02
EP0822813A1 (en) 1998-02-11
CN1187768A (zh) 1998-07-15
EE03553B1 (et) 2001-12-17
HUP9801946A2 (hu) 2000-05-28
US6184219B1 (en) 2001-02-06
PL183997B1 (pl) 2002-08-30
AU5520296A (en) 1996-11-18
NZ306602A (en) 1999-04-29
AU696356B2 (en) 1998-09-10
NO974921L (no) 1997-12-18
TW458777B (en) 2001-10-11
HK1002853A1 (en) 1998-09-25
KR100419810B1 (ko) 2004-04-21
PT822813E (pt) 2002-10-31
US6184218B1 (en) 2001-02-06
US6169098B1 (en) 2001-01-02
SE9501567D0 (sv) 1995-04-27
PL323083A1 (en) 1998-03-02
YU25696A (sh) 1999-06-15
JPH11504037A (ja) 1999-04-06
HUP9801946A3 (en) 2000-12-28
WO1996033710A1 (en) 1996-10-31

Similar Documents

Publication Publication Date Title
NO974921L (no) Kombinasjon av en 5-HT-opptaksinhibitor med en selektiv 5-HT1A antagonist
ID19602A (id) Piridin tersubstitusi sebagai inhibitor selektif siklooksigenase-2
ID18142A (id) Inhibitor metaloprotease 1,4-heterosiklik
ID18141A (id) Inhibitor metaloprotease 1,3-diheterosiklik
DE59606658D1 (de) Schlagunterstütztes Handbohrgerät
KR970701689A (ko) 이소프레닐 전이효소 억제제
MA24215A1 (fr) Composes inhibiteurs de squalene-synthetase
DE69602724D1 (de) Bohrlochwerkzeug
ID18416A (id) Inhibitor metaloprotease diheterosiklik
DE69519995T2 (de) Apolipoprotein-b syntheseinhibitoren
ID18417A (id) Inhibitor ditentat metaloprotease
DE69613077T2 (de) Bohrfutter
DE69633529D1 (de) Bestimmung des Justierbits
DE69523450T2 (de) Inhibitor
EE200000143A (et) Selektiivse 5-HT 1A antagonisti kombinatsioon selektiivse h5-HT 1B antagonisti või osalise agonistiga
DE59604134D1 (de) Bohrkrone
AT265U3 (de) Bohrkrone
DE69626503D1 (de) Bohrvorrichtung
DE29510475U1 (de) Handbohrmaschine
DE9413297U1 (de) Bohrerschaftverlängerung
DE29509681U1 (de) Handbohrmaschinenwasserwaage
DE59710213D1 (de) Bohrgestänge
DE69616456T2 (de) Drillmaschine
DE29521649U1 (de) Bohrgerät
DE29516074U1 (de) Spiralbohrerschaft

Legal Events

Date Code Title Description
ERR Erratum

Free format text: KOMBINASJON AV EN 5-HT-OPPTAKSINHIBITOR MED EN SELEKTIV 5-HT1A ANTAGONIST, FORMULERING OG KIT INNEHOLDENDE EN SLIK KOMBINASJON, FREMGANGSMATE FOR DENS FREMSTILLING, OG ANVENDELSE DERAV